Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Gary,
Instead of posting a ‘War & Peace’ length comment based solely on unfounded conjecture & speculation, why not wait until the MHRA decision is made ?
Which is just two months away at most, or maybe a lot sooner ?
Our current market cap is under $600 million, hardly what would be expected for a company near approval of a potentially blockbuster product being approved near term in the UK. The question is, what should our market cap be after UK approval.
Personally I can't imagine anything below $2 billion, but expect it could be much higher in the $5 to $10 billion range. I believe much depends on the media coverage we get on release of the news, and then on what's planned to follow it.
I've not spoken with DI for some time, however others who have make it sound like far more than UK approval will be rolled out after the UK approval. Certainly we can expect the announcement of an Annual Meeting. Is it possible we'll also get news of submissions, or planned submissions to other regulators. An EDEN update certainly is possible, could we be closer to its acceptance than we think. New trials should certainly be in discussion in the not to distant future, perhaps in partnership with other companies.
My point is that depending on what's rolled out, and the timing on all that should be happening during the remainder of the year, our market cap by years end could be as low as a few billion to as high as well into double digit billions. Unless some country piggy-backs on the UK approval, I don't know that we'll have additional approvals this year. As a guess, if anyone were getting in on the UK approval it could be the Canadians given their close relations with the UK. I would suppose the same could be true of places that weren't involved in the trial, but are closely related to the UK, like Australia. Not everyone would wait for the US approval to act.
The market cap today certainly indicates that few who know of NWBO believe the approval is that near, but when it happens they'll be proven wrong. I suspect that most of the new investors who invest on the news of approval will not have heard of NWBO before that day. If media coverage is strong, and investment becomes emotional, no telling how high the market cap could be taken by investors who look at a stock based on its price, and not its market cap. A $20, $30, or even $50 stock sounds cheap if the headlines say the technology may be applied to all solid cancers, and frankly it could be cheap after it's proven to work in most solid cancers, but in looking at the shares outstanding it's not justified by UK approval for GBM or even all brain cancers alone. It's never been my intention to sell the majority of my stock, but if emotion takes over and carries the stock well over a $10 billion market cap, I believe many of us would be either selling, or placing trailing stop loss orders to guarantee tremendous gains, and looking to purchase substantially more stock after a healthy retrenchment.
There have only been a few times in my life that I can remember such buying on emotion, the biggest was based on a NY Times article on Judah Folkman that took a company from $1 to over $100 on curing cancer in mice. I'm not saying this could be repeated here, but in that case, it cured mice, not people, in our case, over time, it may be found that our vaccine does provide substantial benefit for patients with many forms of solid cancer and over time that should justify triple digit billion market caps, or more.
Gary
Tits4brains,
Who’s been doxed ?
learningcurve2020,
I have heard “Buy when others are selling and sell when others are buying”. By the way, were Amazon or Fed Ex ever messy? Bookstores and Vegas as I recall; ). Believers were well rewarded. Best wishes.
Talk about anything but. Let's talk IP's today instead. Eye rolls.
Wow, you know a lot about this stuff. Now tell me who did the server attack on virtualtrials.org on May 10.
I think someone else picked up on it, but supposedly its a mistake to say who. 😄
My lawyers are on it
Link could be DMed and personalized to each individual.
In PA it sounds like, because my whole family is from the fracking areas and the Amish areas. But I’m down near Philly. Now I want a beer. Haha
lol
keep telling yourself your anonymous
That will play well for the court
I’m British, so my spelling is correct 🤡🤣
Try looking out of the window occasionally 👀😅
defence
noun UK (US defense)
defence noun (PROTECTION)
the act of protecting someone or something against attack or criticism :
He published an essay in defence of the freedom of the press.
These people have died in the defence of liberty.
She angrily came to her friend's defence.
Not necessarily iHub. You can capture peoples IP addresses my having them click an unsuspecting link, too.
Guy deleted the account. I always miss the good stuff
Imaginary purchases .. lol
U have been here 10+ years and u don’t own any shares
Captain checkmated on that one. LOL
I really don’t care
I have nothing to hide
It is. 18 acres of woods in the middle of Amish/farm country. Hopefully all the fracking in the area won't get too close.
I would reach out to that user on Twitter, because your IP was posted too mani.
Here's my best guess:
Bigger -Maybe still in it??
Joan -Out
Hemphill -Out
Hefner -Out
Thermo (whoever he is) -Out
That sounds wonderful.
Not not you, it was ex's IP. Sorry.
I dont care either. I was just replaying what people are posting on X/Twitter and find it interesting. People are mad about market manipulation and some will go to great length to try stop it. They, retail look at it like a David vs. Goliath situation. I have my popcorn and only a spectator in all this. lol
Well, anyone who finds me, c'mon up. I'm way out in the country, and have a 1/3 mile long driveway, on a ridge. I'll see you coming. Call ahead, and I'll pick up your choice of beer. We can laugh about NWBO, and the characters in this place.
You have no business here. You previously admitted you never were part of this trial. You have no information about this trial. You are pretending to be various things from a patient, who was rejected from the trial, to a complainant against King’s College and now you’re claiming to have been a regulator.
Personally, I think you’re an obsessed crazy person with just enough coherence and psychopathy, to keep your little scam here going. But the reality is you have zero information. And you keep trying to fool retail investors otherwise.
not your IP Captain, it was exwannbes IP that was posted on twitter. If what was posted on X was true, Ihub had some serious flaws in its security. I am not a IT expert so no idea if what was posted on X was real or not, only that the person posting was stating it was. Supposedly Ihub corrected it last night, but all the info is out there on X, and people are stating they are digitally capturing all of it.
It's in the fridge. I've got Voodoo Ranger IPA, and my wife's Coors Light
BTW the dark forces issue you check or pay you cash?
And you do know even in UK impersonating a government officer with the intent to deceive is considered a crime?
I am only concerned about your intent.
Clueless fool
I'm coming over, have the beer cold :)
Is that your defence ?
Really? Me?
Lol there's not much to know, or hide.
In a way, I think a site like this should be as open as something like Facebook, so we know where everyone's coming from, so to speak. But, I don't care much, really. Their dialog tells you what you most of what you need to know.
100% true mate.
It matters not a jot to me whether you believe me or not.
It is also true that I was proudly in the British Army.
Again, you really do over- inflate your importance, if you feel that I really actually care about whether or not, you believe the veracity of those two statements of fact ! LOL
Thank you all. Not an important subject, I guess. Better to discuss imaginary purchases all day than get to the bottom of who really owns what.
Yes, Ihub was allowing the user IP address to be obtained. I guess they corrected the issue but not before the "damage" was done. You were one of the many users that this guy posted IP addresses for. I also seen the email (it also was posted on X) where they digitally captured the IP address images and they were sent to legal minds in NYC. I am just relaying what I seen on twitter. I guess blame Ihub as they allowed this to happen.
It will be interested though if this other guy digs-up the physical addresses and actually posts them. We will probably learn a lot about some of the motives of posters here.
I have a ton at 0.17, and 2 tons at .0199 - fat and happy? Yes.
Keep in mind, today is only day 138 from submittal so we have a ways to go while we wait in limbo....
Unfortunately, until then, expect it to continue until we get news.
Say it with me Femy, ‘where’s the MAA?’
Might threaten that 52 week low pretty soon, here. Lots of support at $0.40, though, so it may not break with the Q due up.
Pretty good uptick in volume. Gonna set a buy order for $0.39 just in case some folks see this as a good time to try a flash raid.
Well there is the . 02 cents down every day..fck
Followers
|
1624
|
Posters
|
|
Posts (Today)
|
138
|
Posts (Total)
|
689332
|
Created
|
02/02/05
|
Type
|
Free
|
Moderators XenaLives sentiment_stocks CaptainObvious Poor Man - Doc logic JerryCampbell |
“Now this is not the end. It is not even the beginning of the end. But it is, perhaps, the end of the beginning.”
~ Winston Churchill
Stylized Dendritic Cell featured on NWBO board since 2015
- Dr. Linda Liau, PhD, MBA, Professor and Chair, Department of Neurosurgery, David Geffen School of Medicine at UCLA
Clinical Trials
DCVax®-L to Treat Newly Diagnosed GBM Brain Cancer (NCT00045968) - Phase III (Double Blind)
UK (MHRA): DCVax-L to Treat Newly Diagnosed GBM Brain Cancer (EudraCT#) 2011-001977-13
DE (Germany - PEI): DCVax-L to Treat Newly Diagnosed GBM Brain Cancer (EudraCT#) 2011-001977-13
Expanded Access Protocol for GBM Patients with Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221 (NCT02146066) (Expanded Access)
Safety and Efficacy Study of DCVax-Direct in Solid Tumors (NCT01882946) - Phase I/Phase II (Open Label)
UK Clinical Trials - Study of a Drug (DCVax®-L) to Treat Newly Diagnosed GBM Brain Cancer
EU Clinical Trials for DCVax-L - Phase III
Dendritic Cell Vaccine for Patients with Brain Tumors (NCT01204684) - Phase II - at UCLA - Randomized (Open Label) testing DCVaccine with Resiquimod and DC Vaccination with Adjuvant polyICLC
Pembrolizumab and a Vaccine (ATL-DC) for the treatment of Surgically Accessible Recurrent Glioblastoma - Phase 1 (NCT04201873)
Dendritic Cell-Autologous Lung Tumor Vaccine (DCVax-L) and Nivolumab in Treating Patients with Recurrent Glioblastoma - Phase 2 (NCT03014804)
Dendritic Cell Therapy for Brain Metastases From Breast or Lung Cancer (NCT0368765) - Phase 1 - Collaborator: Mayo Clinic
Announcement of DCVax-L and Anti-PD-1 Monoclonal Antibody (Pembrolizumab) for Patients with Liver Metastases of Primary Colorectal Carcinoma Phase 2 Trial - November 17, 2016 - University Medical Center (UMC) of the Johannes Gutenberg University of Mainz
Cognate Bioservices - Owned by Charles River Labs
Website
Company Contact Info
Investor Relations:
Les Goldman (Company) (202) 841-7909 lgoldman@nwbio.com
Sign up for Northwest email list here (hit the subscribe to email list button in the lower right)
Company Headquarters
4800 Montgomery Lane, Suite 800, Bethesda, MD 20814 (240) 497-9024
NW Bio is developing cancer vaccines designed to treat a broad range of solid tumor cancers more effectively than current treatments, and without the side effects of chemotherapy drugs. NW Bio’s proprietary manufacturing technology enables them to produce its personalized vaccine in an efficient, cost-effective manner. NW Bio has a broad platform technology for DCVax dendritic cell-based vaccines.
Their lead product, DCVax-L, is currently in a 331-patient Phase III trial for patients with newly diagnosed Glioblastoma multiforme (GBM), the most aggressive and lethal brain cancer. This trial is currently underway at 69 locations thoughout the United States, Germany and the United Kingdom. NW Bio has also conducted a Phase I/II trial with DCVax-L for late stage ovarian cancer together with the University of Pennsylvania.
Their second product, DCVax-Direct, is currently in a 60-patient Phase I/II trial for direct injection into all types of inoperable solid tumor cancers, with trials currently being conducted at both MD Anderson Cancer Center in Texas, as well as Orlando Health in Florida.
They previously received clearance from the FDA for a 612-patient Phase III trial with its third product, DCVax-Prostate, for late stage prostate cancer.
DCVAX Survival Stories & Testimonials
Alice - Metastic Merkel Cell patient from Florida - ASCO 2018
Brad Silver - GBM patient from Huntington Beach, California - ASCO 2018
Sarah Rigby - GBM patient from Hong Kong - ASCO 2018
Kristyn Power - daughter of GBM patient from Canada - ASCO 2018
Kat Charles - GBM patients from UK - ASCO 2018 - as related by her husband Jason (Kat's Cure)
Prospective patients may contact NW Bio at patients@nwbio.com
UCLA Jamil Newirth DCVax-Patient Video - 2015
Allan Butler Video - National Geographic Vice President - DCVax-Direct patient from Phase 1 Trial with Pancreatic Cancer
NWBO - Patients Sunday Dennis and Jami Newirth - Enrolled at UCLA - Vimeo, Uploaded approx. May 2015
NWBO - Vaccine Helps Keep Brain Cancer Patient Alive (Jennifer Sugioka) - NBC Channel 4, Southern California, February 24, 2015
NWBO - National Geographic's Allan Butler Stage IV Pancreatic Patient using DCVax-Direct at MD Anderson
NWBO GBM Brain Cancer Survival Story of Mark Pace
Presentations
UCLA Agreements
Prostrate
DCVax-Phase II
DCVax-Booster
Upcoming Events
Videos
Linda M. Liau, MD, PhD, MBA - April 24, 2019 at University of Washington, Neurosciences Institute
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |